MiR ‐595 Suppresses the Cellular Uptake and Cytotoxic Effects of Methotrexate by Targeting SLC19A1 in CEM/C1 Cells
This study helped us to understand the mechanisms underlying the variable MTX responses observed in ALL patients.
This article is protected by copyright. All rights reserved.
Source: Basic and Clinical Pharmacology and Toxicology - Category: Drugs & Pharmacology Authors: Shu ‐Mei Wang, Lu‐Lu Sun, Wan‐Shui Wu, Dan Yan Tags: Original Article Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Drugs & Pharmacology | Genetics | Leukemia | Methotrexate | Pediatrics | Study | Toxicology